TipRanks
Go Ultimate55% OFF

Champions Oncology (2I3) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

2I3 Analyst Ratings

There are no analyst ratings in the last 3 months.

2I3 Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2I3
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Craig-HallumEUR 10.71buy155.05%UpsideReiterated12/16/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Champions Oncology

3 Months
Matt Hewitt
Matt HewittCraig-Hallum
Success Rate3/12 ratings generated profit
25%
Average Return
-1.69%

Copying Matt Hewitt's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -1.69% per trade.

1 Year
Matt Hewitt
Matt HewittCraig-Hallum
Success Rate5/12 ratings generated profit
42%
Average Return
+4.65%

Copying Matt Hewitt's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.65% per trade.

2 Years
Matt Hewitt
Matt HewittCraig-Hallum
Success Rate5/12 ratings generated profit
42%
Average Return
-8.01%

Copying Matt Hewitt's trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of -8.01% per trade.

2I3 Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 2I3
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 2I3 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2I3 average Analyst price target in the past 3 months is ―.

2I3 Financial Forecast

EUR -2EUR -1.25EUR -0.5EUR 0.25EUR 1Q3 2026Q1 2027Q2 2027
ConsensusEUR 0.04

2I3 Earnings Forecast

Next quarter’s earnings estimate for 2I3 is EUR 0.04 with a range of ― to ―. The previous quarter’s EPS was EUR 0.04. 2I3 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2I3 has Performed in-line its overall industry.

EUR 12.3MEUR 13MEUR 13.6MEUR 14.2MEUR 14.8MQ3 2026Q1 2027Q2 2027
ConsensusEUR 13.6M

2I3 Sales Forecast

Next quarter’s sales forecast for 2I3 is EUR 13.59M with a range of ― to ―. The previous quarter’s sales results were EUR 13.59M. 2I3 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2I3 has Performed in-line its overall industry.

2I3 Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Champions Oncology?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Champions Oncology?
To buy shares of DE:2I3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.